Evidence map›Paper›PMID 8170984›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1994

Allelotyping of butadiene-induced lung and mammary adenocarcinomas of B6C3F1 mice: frequent losses of heterozygosity in regions homologous to human tumor-suppressor genes.

R W Wiseman, C Cochran, W Dietrich, E S Lander, P Söderkvist

Open access · greenAbstract readComparative Study
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Mouse mammary tumor virus/v-Ha-ras transgene-induced mammary tumors exhibit strain-specific allelic loss on mouse chromosome 4.Proceedings of the National Academy of Sciences of the United States of America · 1997
    Article
  7. Article
  8. An improved method for the isolation of type II and Clara cells from mice.In vitro cellular & developmental biology. Animal · 1995
    Article
  9. Genetic map of the region surrounding the retrovirus restriction locus, Fv1, on mouse chromosome 4.Mammalian genome : official journal of the International Mammalian Genome Society · 1995
    Article
  10. Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19.Mammalian genome : official journal of the International Mammalian Genome Society · 1994
    Article
  11. Intracisternal A-type particle elements as genetic markers: detection by repeat element viral element amplified locus-PCR.Mammalian genome : official journal of the International Mammalian Genome Society · 1994
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

R W WisemanLaboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC 27709.
C Cochran
W Dietrich
E S Lander
P Söderkvist
National Institutes of Health · USNational Institute of Environmental Health Sciences · US

Funding

MOUSE GENOMIC MAPPINGP50HG000098 · NHGRI · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI COHEN, DANIEL · 1991 to 1998
–
MOUSE GENETIC MARKERS USING DENATURING GRADIENT GELSR01HG000126 · NHGRI · TUFTS UNIVERSITY BOSTON · PI GRAY, MARK · 1990 to 1992
–
NHGRI NIH HHS P50 HG00098NHGRI NIH HHS R01 HG00126
6 · The paper itself

Abstract

To identify the potential involvement of tumor-suppressor gene inactivation during neoplastic development in B6C3F1 mice, genetic losses were determined from allelotypes of butadiene-induced lung and mammary adenocarcinomas. By using length polymorphisms in restriction fragments and simple sequence repeats, or "microsatellites," markers on each autosome were analyzed for allele losses in tumor DNAs. Losses of heterozygosity on chromosome 11 were observed at several loci surrounding the p53 tumor-suppressor gene (Trp53) in 12 of 17 mammary tumors and 2 of 8 lung tumors. Although most of these alterations appeared to result from nondisjunction, at least two examples of somatic recombination or deletion were also observed. Southern analysis revealed a homozygous deletion of the remaining Trp53 allele of one of these mammary tumors. Losses of heterozygosity were also detected at the Rb-1 tumor-suppressor gene in 7 of 17 mammary tumors and 1 lung tumor. Finally, frequent allele losses were observed on chromosome 4 in lung tumors. Analysis of nine chromosome 4 loci defined an interstitial deletion containing the Ifa gene cluster in one of the lung tumors. A tumor-suppressor gene was previously mapped to this region of chromosome 4 in studies with somatic cell hybrids. In addition, homozygous deletions have been reported in a homologous region of human chromosome 9p for acute lymphocytic leukemias, glioblastomas, melanomas, and lung carcinomas. These findings suggest that the inactivation of tumor-suppressor genes including Trp53, Rb-1, and an unidentified gene on chromosome 4 plays a significant role during carcinogenesis in mice.

Indexed as

Genes, Tumor SuppressorAdenocarcinomaAllelesAnimalsBase SequenceButadienesChromosome MappingDNA, NeoplasmDNA PrimersFemaleGenes, RetinoblastomaHeterozygoteHumansLung NeoplasmsMaleMammary Neoplasms, Experimental1,3-butadieneButadienesDNA, NeoplasmDNA Primers

Identifiers

PMID8170984
PMCPMC43661
OpenAlexW2084647543

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.